OR WAIT null SECS
Industry news focusing on the people and organizations who work in the clinical trials profession.
• Biomedical Research Alliance of New York (New York, NY) has made several new hires including Carmela Houston-Henry as Business Development Director and Rich Green as Central IRB Business Development Director.
• Pamela Pannier has joined Clinical Trials of America (Eugene, OR) as Clinical Operations Director and Donald Dickerson has joined as the company's new President.
• With over 20 years of sales, marketing, and business development experience within the pharmaceutical arena, Rick Coulon has been appointed Director of Business Development at PharmOptima (Portage, MI).
• Previously Chief Operating Officer of Clinigene, A. S. Arvind, MD, has been appointed as Strategic Advisor of Ecron Acunova (Bangalore, India).
A.S. Arvind, MD
• Making several additions to its team, AAIPharma Services (Wilmington, NC) has appointed Tim Martin as Executive Vice President of Sales and Marketing, and Rob Goshert as Vice President of Corporate Accounts.
• To streamline the recruitment "pull-through" process and help study sites and sponsors succeed with their patient recruitment efforts, MediciGlobal (Philadelphia, PA) has opened the Study Resource Center and hired Pat Patterson as its Director.
• Pharma Tech Industries (Royston, GA) has appointed Bryan J. Cox as Staff Engineer.
• James W. Lovett, General Counsel of Covance, has been appointed to BioClinica's (Newtown, PA) Board of Directors.
• Edward Masterson has joined Alliance Life Sciences Consulting Group (Bridgewater, NJ) as Senior Vice President of Consulting Operations where he will oversee all aspects of ALSCG consulting services, including solution development and service delivery to clients.
• Bringing with her over 18 years of strategy experience, Rosemarie Truman has been hired as Advanced Clinical's (Deerfield, IL) Executive Vice President of Solutions.
• The Society for Clinical Data Management (Milwaukee, WI) has appointed Nimita Limaye and Ludo Reynders, PhD, as Chairs for its Board of Trustees.
• CTI Clinical Trial and Consulting Services (Cincinnati, OH) has made several changes to its team. Meredith Boley and Robert McRae have joined as Research Associates and Bill Aronstein has been promoted to Senior Medical Director.
• Ricerca Biosciences (Concord, OH) has appointed William DeMaio, PhD, as Senior Director of the Drug Metabolism and Pharmacokinetics Department and has appointed Douglas K. Fuhrer, PhD, as Senior Director of Drug Safety.
• Ludo Reynders, PhD, has joined the team at Premier Research Group (Philadelphia, PA) as Chief Executive Officer.
• ClinPharm Consulting (Research Triangle Park, NC) has hired Giulia Ghibellini, PhD, to implement a new population pharmacokinetics service.
• David Evans, Chief Information Officer at Octagon Research Solutions (Wayne, PA) was appointed as Chair to the CDISC Advisory Board and Monica Garrett, Vice President, Global Marketing, Octagon, was elected to the position of North America Representative on the Board of Directors.
• Covance (Princeton, NJ) has signed definitive agreements with sanofi-aventis (Paris, France) for Covance to become sanofi-aventis' R&D partner.
• Covance (Princeton, NJ) and INphoton (Indianapolis, IN) have entered into an alliance that will grant Covance exclusive global access to INphoton's intravital microscopy imaging technology and expertise.
• BioClinica (Newtown, PA) has signed a three-year, multi-million dollar agreement for enterprise-wide EDC technology and data management services with a top 10 pharmaceutical company in which BioClinica Express will support nearly 200 studies annually for this organization.
• Cato Research (Durham, NC) has selected BioClinica's (Newtown, PA) clinical trial management system platform to help streamline workflow and facilitate the clinical study processes.
• Richmond Pharmacology (London, UK), Community Research (Cincinnati, OH), and Fundación de Investigación de Diego Puerto Rico (San Juan, Puerto Rico) have selected Logos Technologies' (London, UK) ALPHADAS' early phase, e-source data capture system, and site automation software suite to accelerate and streamline their clinical trial operations and services.
• Charles River Laboratories International (Wilmington, MA) has entered into an exclusive, long-term marketing and distribution agreement with Transposagen Biopharmaceuticals (Lexington, KY).
• PPD (Wilmington, NC) has established an agreement with the Himalayan Institute and Hospital Trust (Uttarakhand, India) to expand its network of investigators in the region.
• PPD (Wilmington, NC) and VirtualScopics (Rochester, NY), have formed a strategic alliance to deliver a comprehensive set of clinical and medical imaging services that will enable biopharmaceutical companies to make faster, more confident decisions on the development of their oncology compounds.
• Dako (Glostrup, Denmark) and Quintiles (Durham, NC) have formed a strategic alliance to advance personalized medicine by collaborating on the co-development of targeted therapies and companion diagnostics.
• Rabinder Buttar, PhD, President and CEO of ClinTec International (Glasgow, Scotland), was named Female Business Leader of the Year at the 2010 Scottish Leadership Awards held in Glasgow.
• Mid*Lands IRB (Overland Park, KS) has been awarded accreditation by the Association for the Accreditation of Human Research Protection Program.
• Almac's (Souderton, PA) Clinical Technologies business unit, a part of Almac Group, has been named one of the Best Places to Work in PA for 2010.
• The European Medicine Agency (London, England) and the European Network of Centers for Pharmacoepidemiology and Pharmacovigilance (London, England) have awarded the first ENCePP study seal to an observational study researching hospitalized patients with Chronic Obstructive Pulmonary Disease.
• A Phase III trial for Aegerion Pharmaceuticals (Bridgewater, NJ) that was conducted by ACR Image Metrix (Philadelphia, PA) was published as an abstract in the online supplement of Atherosclerosis and presented at the 78th European Atherosclerosis Society Congress.
• The former management team for Addrenex Pharmaceuticals has launched a new company, Neuronex Inc. (Morrisville, NC), a specialty pharmaceutical company that develops and commercializes drugs to treat central nervous system diseases and disorders.
• US Oncology (The Woodlands, TX) has enrolled the 1,000th patient in a Phase I clinical trial through its US Oncology Research Network.
• Galderma (Fort Worth, TX) has standardized on the Medidata (New York, NY) Rave electronic data capture and clinical data management platform.
• Almac's Clinical Technologies Division has moved into the Almac Group's new North American Headquarters in Souderton, PA. The company has also successfully completed an inspection of its Clinical Services UK facility, located in Craigavon, by the Medicines and Healthcare products Regulatory Agency.
• Perceptive Informatics (Boston, MA) has incorporated IBM's WebSphere portal and Tivoli Access Manager into its eClinical platform, which provides support for its eClinical Suite.
• Partnering with Sun Labs (Menlo Park, CA), Oracle (Redwood Shores, CA) has created the Oracle Health Sciences Institute in order to focus on research that will accelerate IT innovation to advance personalized medicine and drug delivery.
• PPD (Wilmington, NC) has opened an office in Novosibirsk, Russia in order to strengthen its presence in the region. The company has also consolidated its clinical development operations in Beijing, China, in a new, larger office to support its growing client base in the country and throughout Asia Pacific.
• Clinical Research Advantage (Tempe, AZ) has expanded into the Omaha/Council Bluffs market with the opening of three local area offices in Omaha, Bellevue, and Council Bluffs.
• Trianz Solutions (Herndon, VA) has released Version 6.1 of the Acceliant eClinical Suite for web-based clinical trial management and data collection. The new version of Acceliant provides trial builders the ability to define and import CRF metadata in commonly available formats.
• Oracle Health Sciences (Redwood Shores, CA) released Oracle Clinical Development Analytics 2.0 and Oracle Life Sciences Data Hub 2.1.4
• BioClinica (Newtown, PA) has released its new IVR/IWR platform, Trident IWR, whose interface provides clinical operations personnel with a way to directly set up, monitor, and maintain randomization and supplies for clinical trials.
• PharmaVigilant (Westborough, MA) has enhanced its InSpire electronic data capture system to support multiple languages for the management of complex, large-scale global trials.
• Pegasystems (Cambridge, MA) released its Adverse Event Case Processing solution that collects, manages, and analyzes adverse events both during and after clinical trials.